NCT05496231 2025-02-03A Study on the Immune Response and Safety of an Adjuvanted Human Papillomavirus Vaccine When Given to Healthy Women 16 to 26 Years of AgeGlaxoSmithKlinePhase 1/2 Completed1,080 enrolled 28 charts
NCT00513526 2023-11-14Human Papillomavirus Vaccine Therapy in Treating Men With HIV-1 InfectionAIDS Malignancy ConsortiumPhase 2 Completed112 enrolled 16 charts